Liver: Usefulness of noninvasive biomarkers of fibrosis in chronic liver disease

@article{Quattroni2011LiverUO,
  title={Liver: Usefulness of noninvasive biomarkers of fibrosis in chronic liver disease},
  author={Paola Quattroni},
  journal={Nature Reviews Gastroenterology &Hepatology},
  year={2011},
  volume={8},
  pages={659-659}
}
Disease etiology is a major factor in the performance of noninvasive fibrosis biomarkers, according to new research published in Alimentary Pharmacology & Therapeutics. Moreover, the findings from this large-scale study indicate that APRI (aspartate aminotransferase:platelet ratio index) and Fibrotest (BioPredictive, Paris, France) perform best for the diagnosis of marked fibrosis in patients with chronic liver disease (CLD). Sebastiani and colleagues directly compared the performance of… CONTINUE READING